Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Can web tools replace pharmacokinetic analysis in hemophilia A?

Nagao A et al. Thromb Res. 2019 Jan;173:79-84

Publish date:: January 23, 2019

Key clinical point: Online apps designed to help generate individualized pharmacokinetic profiles supported changes in hemophilia A prophylaxis.

Major finding: Adherence stayed the same or improved in patients whose prophylaxis regimens were changed based on the tool results, while bleeding rates improved for specific patient subsets.

Study details: Prospective study including 39 patients receiving hemophilia A prophylaxis.

Disclosures: Study authors reported disclosures related to Shire, Bayer, Pfizer, Novo Nordisk, CSL Behring, and others.

Read the article here.

Citation:

Nagao A et al. Thromb Res. 2019 Jan;173:79-84.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Bleeding Disorders

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

Hemochromatosis variants may confer 10-fold higher risk of liver cancer,

Hemophilia, von Willebrand disease do not increase postop complications for ACL reconstruction,

Mouth splints decrease risk of post–dental extraction bleeding in hemophilia,

Low VWF levels or blood group O not linked to intracerebral hemorrhage risk,